The rate of HPV, a sexually transmitted virus that is the main cause of cervical cancer, has...


The rate of HPV, a sexually transmitted virus that is the main cause of cervical cancer, has dropped 56% among 14-19 year-old young women since the first vaccine was introduced by Merck (MRK) in 2006. The results have been so good that the director of the Centers for Disease Control & Prevention, Thomas Frieden, wants to "protect a generation from cancer" by increasing vaccination. Merck's drug, Gardasil, generated $1.6B in sales in 2012, while one from GlaxoSmithKline (GSK), Cervarix, earned $428M.

From other sites
Comments (2)
  • rustylwb
    , contributor
    Comments (7) | Send Message
     
    Anything that can drop cancer rates this much has to be Good. I'm glad that Texas has adopted a plan for Shot's for all Girls in this age range.
    20 Jun 2013, 12:33 PM Reply Like
  • biochemist
    , contributor
    Comments (680) | Send Message
     
    The HPV vaccine is one of the great triumphs in human health. For the first time ever we have a vaccine that actually prevents a form(s) of cancer. The scientists at MRK, GSK, in the government, and in academia who made this possible all deserve to share the Nobel Prize in Medicine & Physiology.
    20 Jun 2013, 03:55 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs